Afferent arm
|
Pathways
|
Effect |
Change of the gut microbiota due to usage of antibiotics/infectious agents/probiotic bacteria |
Alteration in the circulating levels of pro/anti-inflammatory cytokines that affect brain function |
Modulation of various host metabolic reactions |
Production of essential metabolites (bile acids, choline, short-chain fatty acids) |
Generation of neurotransmitters or neuromodulators in the intestinal lumen |
Induction of epithelial cell release of molecules that stimulate afferent axons |
Changes in tryptophan metabolism |
Effects on behavior |
Activation of sensory vagal fibers |
Conveyance of information about the state of intestine to the CNS |
Efferent arm
|
Pathways
|
Effect |
HPA axis activation |
Regulation of immune cells locally in the gut and systematically affecting gut permeability, motility, secretion, barrier function and gut microbiota composition |
Anti-inflammatory cholinergic reflex and/or sympathetic activation |
Release of neurotransmitters that may affect gut microbiota composition, intestinal permeability and local immunity |
Activation of CNS regulatory areas of satiety |
Impact on nutrient availability to intestinal microbiota and their composition |